ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,424,000 | +35.2% | 8,274 | -1.4% | 0.08% | +40.4% |
Q2 2021 | $1,053,000 | -26.1% | 8,389 | -20.1% | 0.06% | -29.6% |
Q1 2021 | $1,424,000 | +72.8% | 10,503 | +63.1% | 0.08% | +37.3% |
Q4 2020 | $824,000 | -58.7% | 6,441 | -63.6% | 0.06% | -9.2% |
Q3 2020 | $1,994,000 | -34.1% | 17,718 | -44.2% | 0.06% | -16.7% |
Q2 2020 | $3,024,000 | +102.7% | 31,737 | +91.2% | 0.08% | +100.0% |
Q1 2020 | $1,492,000 | +69.0% | 16,599 | -0.3% | 0.04% | +225.0% |
Q4 2019 | $883,000 | – | 16,651 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |